Extended Pleurectomy Decortication and Chemotherapy vs Chemotherapy Alone for Pleural Mesothelioma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Respiratory Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
Lancet Respir Med 2024 May 10;[EPub Ahead of Print], E Lim, D Waller, K Lau, J Steele, A Pope, C Ali, R Bilancia, M Keni, S Popat, M O'Brien, N Tokaca, N Maskell, L Stadon, D Fennell, L Nelson, J Edwards, S Tenconi, L Socci, RC Rintoul, K Wood, A Stone, D Muthukumar, C Ingle, P Taylor, L Cove-Smith, R Califano, Y Summers, Z Tasigiannopoulos, A Bille, R Shah, E Fuller, A Macnair, J Shamash, T Mansy, R Milton, P Koh, AA Ionescu, S Treece, A Roy, G Middleton, A Kirk, RA Harris, K Ashton, B Warnes, E Bridgeman, K Joyce, N Mills, D Elliott, N Farrar, E Stokes, V Hughes, AG Nicholson, CA RogersFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.